Back to all publications

Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity – authors’ reply

Flint A, Andersen G, Hockings P, Plum-Mörschel L, Loomba R

 

Alimentary Pharmacology & Therapeutics. 2021 December

View abstract Share on Linkedin Share on Twitter